Navigation Links
Pharmasset Reports Fiscal Year End 2009 Financial Results
Date:11/25/2009

PRINCETON, N.J., Nov. 25 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS), a clinical stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections, reported financial results for the fiscal year ended September 30, 2009. At September 30, 2009 Pharmasset held $58.4 million in cash, cash equivalents and short term investments.

Pipeline Update and 2009 Highlights

RG7128

Phase 2b Trial

In late November 2009, an independent Data Monitoring Committee (DMC) reviewed the safety and efficacy data from the first approximately 100 patients in cohort 1 and concluded that based on these data the remaining approximately 300 patients can be safely enrolled in the phase 2b study. The DMC reviewed any potential drug discontinuations, incidence and details of adverse events, and selected laboratory assessments. No safety events in the DMC review were considered significantly different from those expected from HCV patients taking peginterferon and ribavirin treatment. The DMC did not recommend modification of dose or duration of any RG7128 dosing regimens. Enrollment of these patients pre-screened for this cohort in the fourth quarter of 2009 has begun and is expected to be complete by the end of the first quarter of 2010.

This phase 2b trial is anticipated to enroll approximately 400 treatment-naive, genotype-1 or genotype-4 HCV-infected patients. The five arm trial, initiated in April 2009, is evaluating the dose and duration of RG7128 in combination with peginterferon plus ribavirin. The primary efficacy endpoint of the trial is the proportion of patients that achieve a sustained virologic response (SVR).

In the first quarter 2010, Roche plans to initiate longer duration, phase 2b studies with
'/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C
2. Pharmasset to Present at Lazard Capital Markets Healthcare Conference
3. Pharmasset Reports Positive Preliminary Antiviral Data With PSI-7851 for the Treatment of Hepatitis C
4. Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences
5. Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C
6. Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients
7. Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
8. Pharmasset Reports Fiscal Year End 2008 Financial Results
9. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
10. Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications
11. Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday, September 24th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... Nov. 28, 2014 /CNW Telbec/ - Ergoresearch Ltd (TSXV: ERG) ... under the « Équilibre, orthèses et biomécanique» banner  – ... 30, 2014. All dollar amounts in the present release are ... quarter of fiscal year 2015 ended this past September 30, ... compared to revenues of $ 4 227 942 for the quarter ...
(Date:11/28/2014)... 2014 According to MedlinePlus, back pain will affect ... lifetime. For many, these pains are only temporary, for others, ... a variety of factors. For those whose chronic pain is ... option. While there are a variety of surgical options out ... M. Rezaian , M.D., Ph.D., F.R.C.S., F.I.C.S. has several advantages ...
(Date:11/28/2014)... 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... its wholly owned subsidiary, Valeant Pharmaceuticals International, will ... outstanding 6.875% Senior Notes due 2018, CUSIP Nos. ... 29, 2014 and has mailed an irrevocable notice ... approximately US$500 million aggregate principal amount of the ...
Breaking Medicine Technology:First Quarter Results fiscal year ended September 30, 2015 - Ergoresearch reports its results for the quarter ended September 30, 2014. 2First Quarter Results fiscal year ended September 30, 2015 - Ergoresearch reports its results for the quarter ended September 30, 2014. 3First Quarter Results fiscal year ended September 30, 2015 - Ergoresearch reports its results for the quarter ended September 30, 2014. 44 Advantages of Laser Back Surgery When Fixing a Herniated Disk 2Valeant Announces Redemption of US$445.0 Million Aggregate Principal Amount of its Outstanding 6.875% Senior Notes due 2018 2
... 2011 Heska Corporation (Nasdaq: HSKA ) today ... by Sidoti & Company, LLC on Monday, January 10, 2011 ... (Park Avenue at Grand Central) in New York City.  The ... (Logo:   http://photos.prnewswire.com/prnh/20000622/HESKALOGO ) ...
... Gliknik Inc ., a biopharmaceuticals company creating ... equity financing completed at a premium price. In the ... in equity financing. Gliknik expects to use the funds to ... lead recombinant candidate from its first-in-class stradomer™ platform. ...
Cached Medicine Technology:Gliknik Announces Completion of Equity Financing 2
(Date:11/28/2014)... Written and narrated by award winning author ... the “The Happiest Man In the World: Life Lessons ... how and why Project C.U.R.E. came to be. , Raised ... and the Reverend Richard W. Jackson, Dr. Jackson exceeded his ... but realized that he wasn’t happy. Prompted by this realization, ...
(Date:11/28/2014)... Alex Kramer HealthDay Reporter ... kids involved in the kitchen, through cooking classes or at ... according to a recent review. Cooking programs and classes ... behaviors, according to the new research. And, although the review ... suggest that such programs might help children develop long-lasting healthy ...
(Date:11/28/2014)... An inventor and dental assistant from Kent, ... filling and it was almost impossible to reach. "This gave ... said. , The patent-pending Access Light allows for easier use ... of the mouth, as well as avoids harm to the ... to use and clean, it also helps prevent cross-contamination. , ...
(Date:11/28/2014)... York (PRWEB) November 28, 2014 ... ) have now been filed in a New ... metal implants, Bernstein Liebhard LLP reports. , ... Bergen County Superior Court reflects the filing of ... modular-neck hip stems, which were voluntarily recalled on ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Lice Troopers Lice ... of its in-home head lice service for moms in ... the center of Coral Gables on Pone De-leon Blvd in ... Harbor Islands that service Miami-Dade & Broward. Lice Troopers ... in South Florida which has been treating families for several ...
Breaking Medicine News(10 mins):Health News:Thanksgiving Weekend Audiobook Treat! “The Happiest Man In the World: Life Lessons From a Cultural Economist” by Dr. James W. Jackson 2Health News:Want Kids to Eat Better? Get Them Cooking 2Health News:Want Kids to Eat Better? Get Them Cooking 3Health News:More than 2,100 Stryker Hip Lawsuits Included in New Jersey Litigation after Settlement Announcement, Bernstein Liebhard LLP Reports 2Health News:More than 2,100 Stryker Hip Lawsuits Included in New Jersey Litigation after Settlement Announcement, Bernstein Liebhard LLP Reports 3Health News:Lice Troopers Lice Removal Service Expands in Miami-Dade 2
... they attributed symptoms to stress, indigestion and fatigue , , ... ignore or simply don,t recognize the warning signs of ... typical "Hollywood heart attack." , So say the authors ... Heart Association,s annual Scientific Forum on Quality of Care ...
... May 2 In an effort to ... requirements enforced by OSHA, EPA as,well as ... http://www.MSDSonline.com ), a leader in on-demand Material ... Safety (EH&S) management services,today announced the availability ...
... reports find , , FRIDAY, May 2 (HealthDay News) -- Working ... cost the American public $45 billion a year, a new ... of Medicaid and the State Children,s Health Insurance Program, and ... federal, state and local governments and shifted to other payers. ...
... CHICAGO According to a recent study, led by ... and assistant professor of medicine, Northwestern University Feinberg School ... a number of metabolic processes, may increase a womans ... important step forward in cancer genetics research, as it ...
... ... Membership Category, LITTLE ROCK, Ark., May 2 ... of an enhanced website at, http://www.NTOCC.org . The redesigned site contains ... of care challenges and to,raise awareness about transitions of care. Specific ...
... WASHINGTON, May 2 The Lupus Foundation of,America joins ... observing World Lupus Day on May 10. More than ... face an unpredictable,future as they struggle daily with the ... Lupus is the result of an unbalanced immune system ...
Cached Medicine News:Health News:Younger Women Often Miss Signs of Heart Attack 2Health News:Younger Women Often Miss Signs of Heart Attack 3Health News:MSDSonline Expands On-Demand Training Offering 2Health News:Government Picks Up Health Tab of Uninsured Workers 2Health News:Government Picks Up Health Tab of Uninsured Workers 3Health News:Government Picks Up Health Tab of Uninsured Workers 4Health News:Study shows gene variations may predict risk of breast cancer in women 2Health News:Healthcare Coalition Launches Enhanced Website Offering Tools and Materials to Improve Patient Care During Transitions of Care 2Health News:Healthcare Coalition Launches Enhanced Website Offering Tools and Materials to Improve Patient Care During Transitions of Care 3Health News:Healthcare Coalition Launches Enhanced Website Offering Tools and Materials to Improve Patient Care During Transitions of Care 4Health News:Healthcare Coalition Launches Enhanced Website Offering Tools and Materials to Improve Patient Care During Transitions of Care 5Health News:Lupus Organizations Issue International Call-to-Action to Combat Disease Affecting Five Million People 2
... a fast and versatile automated strip washer which ... is a self contained and programmable instrument. It ... from the gentle dripping of a simple squeeze ... systems. ELx50/12V processes 1 x 12 strips or ...
... High throughput washer for ... high throughput system washer ... more powerful dispensing line ... a stronger, external vacuum ...
High-quality microplate washer with robot compatibility. It offers additional washing capacity, first-rate efficiency in high-throughput and research applications....
The Wellwash 4 Mk 2 combines high performance and flexibility with reliability, simplicity and ease of use....
Medicine Products: